# Shikha Wadhwani

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/shikha-wadhwani/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,139 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 11 |
| i10-index | 11 |
| Last Known Institution | The University of Texas Medical Branch at Galveston |
| OpenAlex ID | https://openalex.org/A5085929764 |
| ORCID iD | 0000-0002-0005-2340 |
| Works | 49 |

## Researcher papers

- [Soluble Urokinase Receptor and Chronic Kidney Disease](https://scholariq.org/papers/soluble-urokinase-receptor-and-chronic-kidney-disease/)
- [Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy](https://scholariq.org/papers/results-from-part-a-of-the-multi-center-double-blind-randomized-placebo/)
- [A Systematic Review of Immune Checkpoint Inhibitor–Associated Glomerular Disease](https://scholariq.org/papers/a-systematic-review-of-immune-checkpoint-inhibitor-associated-glomerular-disease/)
- [Bone marrow-derived immature myeloid cells are a main source of circulating suPAR contributing to proteinuric kidney disease](https://scholariq.org/papers/bone-marrow-derived-immature-myeloid-cells-are-a-main-source-of-circulating/)
- [KDOQI US Commentary on the 2021 KDIGO Clinical Practice Guideline for the Management of Glomerular Diseases](https://scholariq.org/papers/kdoqi-us-commentary-on-the-2021-kdigo-clinical-practice-guideline-for-the/)
- [A possible mechanism of hyperlipidemia in a patient with metastatic non-small cell lung cancer on lorlatinib therapy](https://scholariq.org/papers/a-possible-mechanism-of-hyperlipidemia-in-a-patient-with-metastatic-non-small/)
- [Proteinuria Trajectory and Disease Progression in Children and Adults with IgA Nephropathy/Vasculitis](https://scholariq.org/papers/proteinuria-trajectory-and-disease-progression-in-children-and-adults-with-iga/)
- [The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes](https://scholariq.org/papers/the-feasibility-and-safety-of-obtaining-research-kidney-biopsy-cores-in-patients/)
- [Association of COVID-19 Versus COVID-19 Vaccination With Kidney Function and Disease Activity in Primary Glomerular Disease: A Report of the Cure Glomerulonephropathy Study](https://scholariq.org/papers/association-of-covid-19-versus-covid-19-vaccination-with-kidney-function-and/)
- [Age of Onset and Disease Course in Biopsy-Proven Minimal Change Disease: An Analysis From the Cure Glomerulonephropathy Network](https://scholariq.org/papers/age-of-onset-and-disease-course-in-biopsy-proven-minimal-change-disease-an/)
- [KDOQI US Commentary on the KDIGO 2025 Clinical Practice Guideline for the Management of Immunoglobulin A Nephropathy (IgAN) and Immunoglobulin A Vasculitis (IgAV)](https://scholariq.org/papers/kdoqi-us-commentary-on-the-kdigo-2025-clinical-practice-guideline-for-the/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions/)
- [Renal Transplantation Outcomes and Treatments](https://scholariq.org/topics/renal-transplantation-outcomes-and-treatments/)
- [Amyloidosis: Diagnosis, Treatment, Outcomes](https://scholariq.org/topics/amyloidosis-diagnosis-treatment-outcomes/)

## Researcher university

- [The University of Texas Medical Branch at Galveston](https://scholariq.org/institutions/the-university-of-texas-medical-branch-at-galveston/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.